Novavax (NVAX) Share Now Look Weak
August 19, 2009 · Filed Under General
Shares in Novavax (NVAX) don’t look like they will trade higher. The stock is off almost 4% to $4.65.
NVAX rode up on news that its H1N1 vaccine had shown promise in tests on ferrets. The market was only moderately impressed and the rally in the stock died. If the market keep moving down, NVAX could drop even faster.
Douglas A. McIntyre
